"Targeting Dormant Breast Cancer Cells to Prevent Relapse: New Research Findings"

A breakthrough in breast cancer research has uncovered how to target "hibernating" tumour cells, offering new hope for patients with oestrogen receptor-positive breast cancer. Scientists discovered that hormone therapies can trigger changes in some cells, causing them to lie dormant instead of dying off and leading to a relapse years later. Inhibiting the enzyme G9a prevented cancer cells from becoming dormant and killed the cells that were already hibernating, potentially paving the way for innovative treatments to prevent breast cancer from recurring.